Home › Funds › Clio Asset Management LLC › PVLA

Clio Asset Management LLC position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

Clio Asset Management LLC reported holding 86,012 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q3 2026 13F filing — a position valued at US$11.9M, representing 9.97% of its reported portfolio and ranking #3 among its reported holdings. Clio Asset Management LLC has disclosed PVLA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)86.01K sh
Reported value held$11.86M
Portfolio Weight9.97%
First reportedQ2 2025
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Clio Asset Management LLC's PVLA position evolved

Clio Asset Management LLC first disclosed a stake in PVLA in Q2 2025 at 91,508 shares (US$2.1M). The position peaked in Q2 2026 at 86,343 shares, worth US$13.2M. Across 6 filings, Clio Asset Management LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 86,012 shares valued at US$11.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 91.51K $2.06M New
Q3 2025 91.64K $5.74M Hold
Q4 2025 91.64K $9.59M Hold
Q1 2026 90.76K $11.31M Reduce
Q2 2026 86.34K $13.19M Reduce
Q3 2026 86.01K $11.86M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has Clio Asset Management LLC held PVLA?

Clio Asset Management LLC has disclosed PVLA holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Clio Asset Management LLC's current position in PVLA?

As of Q3 2026, Clio Asset Management LLC holds 86.01K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $11.86M, representing 9.97% of its reported portfolio and ranking #3.

Has Clio Asset Management LLC been buying or selling PVLA?

In the latest 13F filing (Q3 2026), Clio Asset Management LLC held unchanged its position in PVLA. The position peaked in Q2 2026 at 86.34K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.